STAAR Surgical Debt to Equity Ratio 2010-2024 | STAA

Current and historical debt to equity ratio values for STAAR Surgical (STAA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. STAAR Surgical debt/equity for the three months ending September 30, 2024 was 0.00.
STAAR Surgical Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.11B $0.43B 0.26
2024-06-30 $0.10B $0.41B 0.25
2024-03-31 $0.10B $0.39B 0.25
2023-12-31 $0.10B $0.39B 0.27
2023-09-30 $0.09B $0.38B 0.25
2023-06-30 $0.09B $0.35B 0.25
2023-03-31 $0.08B $0.34B 0.24
2022-12-31 $0.08B $0.34B 0.25
2022-09-30 $0.08B $0.32B 0.23
2022-06-30 $0.08B $0.30B 0.26
2022-03-31 $0.08B $0.28B 0.27
2021-12-31 $0.09B $0.26B 0.34
2021-09-30 $0.08B $0.25B 0.30
2021-06-30 $0.06B $0.24B 0.26
2021-03-31 $0.05B $0.21B 0.24
2020-12-31 $0.06B $0.20B 0.31
2020-09-30 $0.05B $0.19B 0.26
2020-06-30 $0.04B $0.18B 0.25
2020-03-31 $0.04B $0.17B 0.25
2019-12-31 $0.05B $0.16B 0.30
2019-09-30 $0.04B $0.15B 0.29
2019-06-30 $0.04B $0.14B 0.29
2019-03-31 $0.04B $0.14B 0.29
2018-12-31 $0.04B $0.13B 0.26
2018-09-30 $0.03B $0.13B 0.27
2018-06-30 $0.03B $0.05B 0.62
2018-03-31 $0.03B $0.05B 0.71
2017-12-31 $0.03B $0.04B 0.58
2017-09-30 $0.03B $0.04B 0.79
2017-06-30 $0.03B $0.04B 0.66
2017-03-31 $0.03B $0.04B 0.77
2016-12-31 $0.03B $0.04B 0.73
2016-09-30 $0.03B $0.04B 0.76
2016-06-30 $0.03B $0.04B 0.72
2016-03-31 $0.02B $0.04B 0.61
2015-12-31 $0.02B $0.04B 0.62
2015-09-30 $0.02B $0.04B 0.57
2015-06-30 $0.02B $0.04B 0.52
2015-03-31 $0.02B $0.04B 0.56
2014-12-31 $0.02B $0.04B 0.59
2014-09-30 $0.02B $0.04B 0.55
2014-06-30 $0.02B $0.04B 0.54
2014-03-31 $0.02B $0.04B 0.56
2013-12-31 $0.02B $0.04B 0.59
2013-09-30 $0.02B $0.04B 0.57
2013-06-30 $0.02B $0.04B 0.58
2013-03-31 $0.02B $0.03B 0.61
2012-12-31 $0.02B $0.03B 0.73
2012-09-30 $0.02B $0.03B 0.59
2012-06-30 $0.02B $0.03B 0.58
2012-03-31 $0.02B $0.03B 0.58
2011-12-31 $0.02B $0.03B 0.66
2011-09-30 $0.02B $0.03B 0.62
2011-06-30 $0.02B $0.03B 0.67
2011-03-31 $0.02B $0.02B 0.72
2010-12-31 $0.02B $0.02B 0.81
2010-09-30 $0.02B $0.02B 0.78
2010-06-30 $0.02B $0.02B 0.72
2010-03-31 $0.03B $0.02B 1.41
2009-12-31 $0.04B $0.02B 1.79
2009-09-30 $0.04B $0.02B 1.64
2009-06-30 $0.04B $0.02B 1.55
2009-03-31 $0.04B $0.01B 2.46
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.192B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.568B 20.89
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
West Pharmaceutical Services (WST) United States $24.592B 50.23
Straumann Holding AG (SAUHY) Switzerland $23.137B 0.00
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09